Alkermes PLC (ALKS)
24.04
+0.27
(+1.14%)
USD |
NASDAQ |
Apr 17, 16:00
23.46
-0.58
(-2.41%)
After-Hours: 20:00
Alkermes Cash from Investing (Quarterly): -20.98M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -20.98M |
September 30, 2023 | -119.36M |
June 30, 2023 | 120.85M |
March 31, 2023 | 72.85M |
December 31, 2022 | 27.74M |
September 30, 2022 | 8.898M |
June 30, 2022 | -40.54M |
March 31, 2022 | -60.64M |
December 31, 2021 | -0.742M |
September 30, 2021 | -31.71M |
June 30, 2021 | 3.977M |
March 31, 2021 | -37.73M |
December 31, 2020 | -35.10M |
September 30, 2020 | -8.227M |
June 30, 2020 | 14.35M |
March 31, 2020 | 17.49M |
December 31, 2019 | -101.47M |
September 30, 2019 | 31.59M |
June 30, 2019 | -7.253M |
March 31, 2019 | -64.70M |
December 31, 2018 | -7.803M |
September 30, 2018 | 26.15M |
June 30, 2018 | -65.88M |
March 31, 2018 | 25.34M |
December 31, 2017 | -14.19M |
Date | Value |
---|---|
September 30, 2017 | -13.60M |
June 30, 2017 | -6.021M |
March 31, 2017 | 15.46M |
December 31, 2016 | -20.88M |
September 30, 2016 | 46.99M |
June 30, 2016 | 28.44M |
March 31, 2016 | 72.69M |
December 31, 2015 | -42.22M |
September 30, 2015 | 30.51M |
June 30, 2015 | -2.989M |
March 31, 2015 | -28.79M |
December 31, 2014 | 46.13M |
September 30, 2014 | -63.69M |
June 30, 2014 | 26.84M |
March 31, 2014 | -272.67M |
September 30, 2013 | -2.67M |
June 30, 2013 | -5.401M |
March 31, 2013 | -111.83M |
December 31, 2012 | -31.30M |
September 30, 2012 | 65.64M |
June 30, 2012 | 9.35M |
March 31, 2012 | -21.58M |
December 31, 2011 | -2.528M |
September 30, 2011 | -399.88M |
June 30, 2011 | 6.824M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-119.36M
Minimum
Sep 2023
120.85M
Maximum
Jun 2023
-8.737M
Average
-7.253M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
Endo International PLC | -11.65M |
Jazz Pharmaceuticals PLC | 101.80M |
Medtronic PLC | -707.00M |
Perrigo Co PLC | -22.80M |
Iterum Therapeutics PLC | 13.52M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 107.24M |
Cash from Financing (Quarterly) | -276.50M |
Free Cash Flow | 353.30M |
Free Cash Flow Per Share (Quarterly) | 0.5405 |
Free Cash Flow to Equity (Quarterly) | 90.84M |
Free Cash Flow to Firm (Quarterly) | 90.21M |
Free Cash Flow Yield | 8.70% |